49 Einträge gefunden

1. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

   1. Kalmanti, Lida
   2. Saussele, Susanne
   3. Lauseker, Michael
   4. Proetel, Ulrike
   5. Müller, Martin C
   6. Hanfstein, Benjamin
   7. Schreiber, Annette

   2014 - Forschungsinformationssystem des UKE
2. Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV

   1. Hehlmann, Rüdiger
   2. Müller, Martin C
   3. Lauseker, Michael
   4. Hanfstein, Benjamin
   5. Fabarius, Alice
   6. Schreiber, Annette
   7. Proetel, Ulrike

   2014 - Forschungsinformationssystem des UKE
3. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

   1. Fu, Yuewen
   2. Schroeder, Thomas
   3. Zabelina, Tatiana
   4. Badbaran, Anita
   5. Bacher, Ulrike
   6. Kobbe, Guido
   7. Ayuketang, Francis Ayuk

   2014 - Forschungsinformationssystem des UKE
4. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
5. Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Alpermann, Tamara
   5. Dicker, Frank
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
6. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

   1. Bacher, Ulrike
   2. Weissmann, Sandra
   3. Kohlmann, Alexander
   4. Schindela, Sonja
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Kern, Wolfgang

   2012 - Forschungsinformationssystem des UKE
7. Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Alpermann, Tamara
   4. Reiter, Andreas
   5. Ulke, Madlen
   6. Dicker, Frank
   7. Eder, Christiane

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
8. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.

   1. Bacher, Ulrike
   2. Kern, Wolfgang
   3. Alpermann, Tamara
   4. Schnittger, Susanne
   5. Haferlach, Claudia
   6. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
9. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.

   1. Haferlach, Claudia
   2. Bacher, Ulrike
   3. Schnittger, Susanne
   4. Alpermann, Tamara
   5. Zenger, Melanie
   6. Kern, Wolfgang
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
10. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.

    1. Haferlach, Torsten
    2. Bacher, Ulrike
    3. Alpermann, Tamara
    4. Haferlach, Claudia
    5. Kern, Wolfgang
    6. Schnittger, Susanne

    2012 - Forschungsinformationssystem des UKE
11. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Torsten
    4. Wendland, Nicole
    5. Ulke, Madlen
    6. Dicker, Frank
    7. Grossmann, Vera

    2012 - Forschungsinformationssystem des UKE
12. Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Eder, Christiane
    4. Dicker, Frank
    5. Alpermann, Tamara
    6. Grossmann, Vera
    7. Kohlmann, Alexander

    2012 - Forschungsinformationssystem des UKE - frei zugänglich
13. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

    1. Bacher, Ulrike
    2. Schnittger, Susanne
    3. Macijewski, Katja
    4. Grossmann, Vera
    5. Kohlmann, Alexander
    6. Alpermann, Tamara
    7. Kowarsch, Andreas

    2012 - Forschungsinformationssystem des UKE
14. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.

    1. Haferlach, Claudia
    2. Bacher, Ulrike
    3. Kohlmann, Alexander
    4. Schindela, Sonja
    5. Alpermann, Tamara
    6. Kern, Wolfgang
    7. Schnittger, Susanne

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
15. Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Kern, Wolfgang
    5. Schnittger, Susanne
    6. Haferlach, Claudia

    2011 - Forschungsinformationssystem des UKE
16. Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Fehse, Boris
    4. Schnittger, Susanne
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
17. Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.

    1. Oyekunle, Anthony
    2. Haferlach, Torsten
    3. Kröger, Nicolaus
    4. Klyuchnikov, Evgeny
    5. Zander, Axel R.
    6. Schnittger, Susanne
    7. Bacher, Ulrike

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
18. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Schnittger, Susanne
    4. Kreipe, Hans
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE
19. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Zenger, Melanie
    5. Hochhaus, Andreas
    6. Beelen, Dietrich W
    7. Uppenkamp, Michael

    2011 - Forschungsinformationssystem des UKE
20. A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Eder, Christiane
    4. Lohse, Peter
    5. Haferlach, Claudia
    6. Kern, Wolfgang
    7. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE